Changnong Peng
Overview
Explore the profile of Changnong Peng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
135
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang A, Zhang H, Xie B, Gao Z, Dong Y, Peng C, et al.
IEEE Trans Biomed Eng
. 2024 Sep;
72(2):747-759.
PMID: 39348255
Objective: Fractional flow reserve (FFR) derived from coronary angiography, referred to as ICA-FFR, is a less-invasive alternative for invasive FFR measurement based on computational fluid dynamics. Blood flow into side...
2.
Guo W, Zhao L, Huang W, Chen J, Zhong T, Yan S, et al.
Cardiovasc Diabetol
. 2024 Apr;
23(1):118.
PMID: 38566143
Background: Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are increasingly recognized for their role in reducing the risk and improving the prognosis of heart failure (HF). However, the precise mechanisms involved remain...
3.
Hu Q, Qu W, Zhang T, Feng J, Dong X, Nie R, et al.
J Am Heart Assoc
. 2024 Feb;
13(4):e030054.
PMID: 38348774
Background: This study investigated whether gCTRP9 (globular C1q/tumor necrosis factor-related protein-9) could restore high-glucose (HG)-suppressed endothelial progenitor cell (EPC) functions by activating the endothelial nitric oxide synthase (eNOS). Methods And...
4.
Yoon E, Zhang W, Cai Y, Peng C, Zhou D
Crit Rev Eukaryot Gene Expr
. 2023 Aug;
33(7):81-90.
PMID: 37602455
The development and progression of atherosclerosis represent a chronic process involving complex molecular interactions. Therefore, identifying the potential hub genes and pathways contributing to coronary artery disease (CAD) development is...
5.
Liu Y, Ke X, Guo W, Wang X, Peng C, Liao Z, et al.
Arch Med Sci
. 2022 May;
18(3):732-745.
PMID: 35591844
Introduction: Myocardial ischemia/reperfusion (I/R) injury is a leading cause of cardiac dysfunction. Circular RNAs (circRNAs) are involved in the pathogenesis of myocardial I/R injury. However, the functions and underlying mechanisms...
6.
Guo W, Zhao L, Mo F, Peng C, Li L, Xu Y, et al.
Diabetes Res Clin Pract
. 2021 Apr;
177:108786.
PMID: 33812901
Aims: The triglyceride glucose (TyG) index is a marker of insulin resistance. However, the prognostic value thereof in patients with chronic heart failure (CHF) and type 2 diabetes remains unclear....
7.
Guo W, Zhao L, Zhao H, Zeng F, Peng C, Guo W, et al.
Ann Transl Med
. 2021 Feb;
9(2):118.
PMID: 33569420
Background: Previous studies have shown that the lactate/albumin (L/A) ratio plays a role in predicting the outcomes of septic shock or severe sepsis. However, the role of the L/A ratio...
8.
Guo W, Peng C, Liu Q, Zhao L, Guo W, Chen X, et al.
ESC Heart Fail
. 2020 Dec;
8(1):250-258.
PMID: 33314789
Aims: The relationship between baseline base excess (BE) and survival outcomes in patients with congestive heart failure (CHF) is unclear. Therefore, we aimed to investigate this relationship based on the...
9.
Guo W, Chen X, Hao Y, Liu Q, Peng C, Zhao L, et al.
Aging (Albany NY)
. 2020 Jul;
12(13):12930-12942.
PMID: 32611835
This study evaluated the benefit of dual therapy in reducing ischemic events in atrial fibrillation (AF) patients presenting with acute coronary syndrome (ACS) or undergoing percutaneous coronary intervention (PCI). We...
10.
Yan S, Liu X, Ke X, Xian Z, Peng C, Wang X, et al.
Int J Lab Hematol
. 2020 Jun;
42(5):661-668.
PMID: 32567809
Introduction: Double antiplatelet therapy (DAPT) has wide inter-individual variabilities in coronary heart disease (CHD) patients' responses, which undermines the prognosis effect in clinical practice. Long noncoding RNAs (lncRNAs) have been...